HSBC Holdings
TNDM icon

HSBC Holdings’s Tandem Diabetes Care TNDM Stock Holding History

HSBC Holdings’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,553
Closed -$810K – 3225
2025
Q4 		$810K Sell
36,553
-56,373
-61% -$1.02M ﹤0.01% 2055
2025
Q3 		$1.08M Buy
92,926
+63,184
+212% +$855K ﹤0.01% 1762
2025
Q2 		$554K Buy
29,742
+15,598
+110% +$309K ﹤0.01% 2094
2025
Q1 		$270K Sell
14,144
-13,635
-49% -$399K ﹤0.01% 2440
2024
Q4 		$1.02M Buy
27,779
+14,501
+109% +$491K ﹤0.01% 1791
2024
Q3 		$560K Buy
13,278
+7,251
+120% +$307K ﹤0.01% 1954
2024
Q2 		$243K Sell
6,027
-59
-1% -$2.46K ﹤0.01% 2436
2024
Q1 		$215K Sell
6,086
-7,489
-55% -$201K ﹤0.01% 2653
2023
Q4 		$405K Sell
13,575
-5,724
-30% -$119K ﹤0.01% 2141
2023
Q3 		$400K Sell
19,299
-1,656
-8% -$45.5K ﹤0.01% 2075
2023
Q2 		$525K Buy
+20,955
New +$674K ﹤0.01% 1953
2023
Q1 		– Sell
-45,636
Closed -$2.05M – 3041
2022
Q4 		$2.05M Buy
45,636
+6,692
+17% +$303K ﹤0.01% 1681
2022
Q3 		$1.86M Sell
38,944
-2,097
-5% -$115K ﹤0.01% 1585
2022
Q2 		$2.43M Buy
41,041
+16,140
+65% +$1.32M ﹤0.01% 1493
2022
Q1 		$2.9M Buy
+24,901
New +$2.91M ﹤0.01% 1427
2021
Q4 		– Sell
-3,980
Closed -$477K – 3360
2021
Q3 		$477K Sell
3,980
-10,379
-72% -$1.14M ﹤0.01% 2280
2021
Q2 		$1.4M Buy
14,359
+10,813
+305% +$964K ﹤0.01% 1602
2021
Q1 		$311K Sell
3,546
-4,984
-58% -$463K ﹤0.01% 2265
2020
Q4 		$812K Buy
8,530
+863
+11% +$88.9K ﹤0.01% 1846
2020
Q3 		$878K Buy
7,667
+2,848
+59% +$299K ﹤0.01% 1607
2020
Q2 		$477K Sell
4,819
-530
-10% -$42.3K ﹤0.01% 1863
2020
Q1 		$354K Buy
5,349
+87
+2% +$6.1K ﹤0.01% 1963
2019
Q4 		$315K Sell
5,262
-165
-3% -$10.2K ﹤0.01% 2512
2019
Q3 		$320K Buy
5,427
+1,363
+34% +$87K ﹤0.01% 2588
2019
Q2 		$262K Buy
+4,064
New +$262K ﹤0.01% 2399

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HSBC Holdings's TNDM Position: Q1 2026 in Review

HSBC Holdings sold out of Tandem Diabetes Care (TNDM) in Q1 2026, closing a stake of 36,553 shares — an estimated $810K sold.

HSBC Holdings first reported a position in TNDM in Q2 2019 and held it in 25 quarters. The position peaked at $2.9M in Q1 2022. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • HSBC Holdings reported no remaining Tandem Diabetes Care position as of Q1 2026 after selling out during the quarter.
  • HSBC Holdings sold 36,553 Tandem Diabetes Care shares in Q1 2026, an estimated $810K.
  • HSBC Holdings first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 25 quarters.
  • HSBC Holdings's Tandem Diabetes Care position peaked at $2.9M in Q1 2022.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.